BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Paradigms Foundation - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://paradigms.foundation
X-WR-CALDESC:Events for Paradigms Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240301T080000
DTEND;TZID=Europe/Paris:20240302T170000
DTSTAMP:20240829T153453Z
CREATED:20240829T153453Z
LAST-MODIFIED:20240829T153453Z
UID:9787-1709280000-1709398800@paradigms.foundation
SUMMARY:INIC 2024
DESCRIPTION:Held from March 1-2\, 2024\, in Riyadh\, Saudi Arabia\, INIC 2024 is the first-ever scientific conference in the region focused on neuroimmunology. Esteemed local and international speakers will deliver cutting-edge presentations aimed at educating both professionals and non-professionals on critical topics such as Multiple Sclerosis (MS) and neuroimmunological diseases. Through these sessions\, the conference is seeking to improve early diagnosis\, enhance interventions\, and empower patients with knowledge and advocacy. \n\n\n\nParadigMS experts are playing a significant role\, presenting on advancements in MS treatments and the integration of AI in personalized medicine. Notable topics include novel therapies targeting microglial cells\, updates on stem cell transplantation for MS\, and the evolving understanding of MS as a continuum of chronic inflammation and disease progression. \n\n\n\nThis groundbreaking conference provides a unique platform for advancing the understanding and management of neuroimmunological diseases\, ultimately aiming to improve patient outcomes across the region. \n\n\n\nThe presentations will be recorded and shared on our platform.
URL:https://paradigms.foundation/event/inic-2024/
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2024/08/INIC-24.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240328T173000
DTEND;TZID=Europe/Paris:20240328T223000
DTSTAMP:20240415T143402Z
CREATED:20240105T104200Z
LAST-MODIFIED:20240415T143402Z
UID:7921-1711647000-1711665000@paradigms.foundation
SUMMARY:ParadigMS 9th Belgian Symposium 2024
DESCRIPTION:ParadigMS Ninth Belgian Symposium promises to be a clinically relevant learning experience\, set against the backdrop of a friendly dinner environment. The event will feature engaging keynotes and clinical case discussions\, providing a unique opportunity for insightful dialogue and professional growth. \n\n\n\nProf. Romain Marignier will share expertise on  \n\n\n\n‘Differential Diagnosis in Multiple Sclerosis\, NMO-SD\, and MOGAD’  \n\n\n\noffering valuable insights that promise to enrich your understanding of these conditions. \n\n\n\nAdditionally\, distinguished clinical biologists\, Mrs. Laurence Lutteri from CHU Liège and Dr. Matthijs Oyaert from UZ Gent\, will present the various diagnostic tests available for MS\, NMO-SD\, and MOGAD.  \n\n\n\nMrs. Lutteri will lead the lecture titled ‘Advances in Clinical Techniques for CNS Inflammatory Diseases‘ in La Hulpe\, and Dr. Oyaert will lead the lecture titled ‘Antibodies in Focus: Advancements in Diagnosing NMO and MOG-related CNS Disorders‘ in Ghent. Their presentations will draw from their extensive hospital experiences\, providing a comprehensive overview of the current diagnostic landscape. \n\n\n\nOur Symposium is helmed by Prof. Bart Van Wijmeersch from UHasselt as the Symposium Chair. Prof. Dominique Dive from CHU Liège and Prof. Guy Laureys from UZ Gent serve as our esteemed Programme Chairs\, facilitating the clinical case discussions. These discussions\, thoughtfully introduced and moderated\, will unfold at each table\, allowing for dynamic interaction and collaborative exploration of challenging cases. \n\n\n\n\n\n\n\n\n\n\nBuy Tickets on Eventbrite\n\nRegister\n\n\n\n\n\n\n\n\n\n\n\nProgrammeSpeakers and abstractsSponsors\n\nMarch 7th\, La HulpeMarch 28th\, Ghent17:45 – 19:00                           Registration and welcome drinks. NetworkingRegistration and welcome drinks. Networking18:15 – 18:45Sponsored break-out AlexionSponsored break-out Alexion19:00 – 19:45Welcome by Mr. Stefaan De Corte\, ParadigMS Manager and by Programme Chair\, Prof. Dominique Dive (CHU Liège) & Main lecture on Differential Diagnosis in MS\, NMO-SD and MOGAD by Prof. Romain Marignier (CHU Lyon)Welcome by Symposium Chair\, Prof. Bart Van Wijmeersch and Programme Chair\, Prof. Guy Laureys (UZGent) & Main lecture on Differential Diagnosis in MS\, NMO-SD and MOGAD by Prof. Romain Marignier (CHU Lyon)19:45 – 20:10First course. Clinical case discussions.First course. Clinical case discussions.20:10 – 20:40Lecture on Advances in Clinical Techniques for CNS Inflammatory Diseases by Dr. Laurence Lutteri (CHU Liège) & Introduction to clinical cases by the Programme Chair and case presentersLecture on Antibodies in Focus: Advancements in Diagnosing NMO and MOG-related CNS Disorders by Dr. Matthijs Oyaert (UZGent) & Introduction to clinical cases by the Programme Chair and case presenters  20:40 – 21:15Main course. Facilitated case presentations and discussions.  Main course. Facilitated case presentations and discussions. 21:15 – 21:45Continued clinical case discussion.  Conclusions by Programme ChairsContinued clinical case discussion.  Conclusions by Programme Chairs21:45 – 22:30Dessert. NetworkingDessert. Networking\n\n\n\n\n\n\n\n\n\nProf. Romain MARIGNIER – MD\, PhD \n\n\n\nPr. Romain Marignier is a neurologist (MD)\, professor in the Neurological Hospital of Lyon\, France. His field of expertise are the neuro-inflammatory disorders of the central nervous system with a specific interest on rare disorders\, namely neuromyelitis optica spectrum disorders (NMOSD) and MOG-Ab associated diseases (MOGAD). Pr Marignier is the coordinator of the French nationwide NMO and MOGAD cohorts and biobanks\, NOMADMUS\, set up in 2010 that includes all the French clinical experts in neuro-inflammatory disorders. Through NOMADMUS\, Pr Marignier provided breakthrough insights in the topic regarding clinical characterization\, management\, and treatment of NMOSD and MOGAD\, supported by major publication in high-profile journals. \n\n\n\nSince 2017\, Pr Marignier is the head of the French referral center for rare inflammatory disorder of the central nervous system (MIRCEM)\, providing expertise on diagnosis and management of NMOSD and MOGAD for both patients and clinicians. \n\n\n\nFinally\, Pr. Marignier achieved a PhD on basic neurosciences in 2011 at Claude Bernard University Lyon 1 on the role of auto-antibodies in NMOSD and related diseases. He actually performs his research at INSERM unit 1028 in Lyon Neuroscience Research Centre (CRNL) on: 1. The pathophysiology of auto antibody- mediated disorders of the central nervous system with in vitro\, ex vivo and animal models; 2. The development of new strategies to optimise detection of auto-antibodies (anti-AQP4\, anti-MOG\, anti-GFAP) for diagnosis and prognosis purpose (immunohistochemistry\, flow cytometry). \n\n\n\nAbstract of talk \n\n\n\nIn the past 20 years\, the concept of antibody mediated demyelinating disorders have emerged. These diseases\, namely Aquaporin-4 (AQP4) positive neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte (MOG)- antibody associated disease (MOGAD)\, share common features with multiple sclerosis\, but are fundamentally different in terms of pathophysiology\, disease course and treatment. In this lecture we will provide a clinical\, biological and imaging description of these two entities\, and propose a focus on the features that helps to differentiate in between these conditions. \n\n\n\nLearning objectives: \n\n\n\n\nto know the diagnostic criteria for NMOSD and MOGAD as compared to MS\n\n\n\n\n\nto identify the situation when to search for AQP4-IgG and/or MOG-IgG  \n\n\n\n\n\nto know the principles of attack and preventive therapies of NMOSD and MOGAD\n\n\n\n\n\n\n\n\n\n\n\n\nDr. Laurence LUTTERI \n\n\n\nDr. Laurence Lutteri has a master in pharmacy and a specialization in laboratory medicine.  \n\n\n\nShe heads the auto-immunity and specialized biochemistry laboratories in the department of clinical chemistry at the University Hospital of Liège. \n\n\n\nShe collaborates in different projects about connective tissue diseases with rheumatologists\, with neurologists for the diagnosis of multiple sclerosis and other inflammatory diseases and also with hematologists for the diagnosis and the follow-up of monoclonal gammopathies. \n\n\n\nImmunofluorescence\, Elisa\, immunodots\,…are the different methods used in her auto-immunity laboratory and electrophoresis\, immunofixation\, turbidimetry\, nephelometry and a lot of different manual techniques in the biochemistry laboratory. \n\n\n\nAbstract of talk \n\n\n\nVarious techniques are used in clinical biology laboratories to diagnose inflammatory diseases of the central nervous system (CNS). Detection of cerebrospinal fluid (CSF)-restricted oligoclonal bands (OCB) has been used for many years to diagnose multiple sclerosis. More recently\, determination of kappa free light chains in CSF/serum has been developed and offers some advantages : fast\, reliable\, rater-independent\, quantitative results – over OCB technique. \n\n\n\nIn the differential diagnosis of demyelinating disorders of the CNS\, the laboratory’s first-line tests are antibodies targeting aquaporin-4 (AQP4) and anti-myelin oligodendrocyte glycoprotein (MOG) autoantibodies on transfected cells (fixed Cell Based Assays (CBA)). In the event of clinically inconsistent results\, flow cytometric analysis (live CBA) would show better performance. \n\n\n\n\n\n\n\n\n\n\n\nDr. Matthijs OYAERT \n\n\n\nDr. Matthijs Oyaert graduated as a master in drug development (pharmacy) in 2011 and master in  clinical biology in 2016 at the KU Leuven and started working as a clinical biologist at the clinical laboratory of the Ghent University hospital. In the laboratory of clinical chemistry and hematology\, he is responsible for a broad variety of (automated) routine clinical chemistry and immunochemistry tests and urinary test strip and particle analysis. In addition\, he is involved in the laboratory diagnosis of auto-immune and neuroinflammatory diseases.  \n\n\n\nDuring the first years\, he obtained his PhD in 2021 entitled “New developments in the laboratory diagnosis of urinary tract pathology” at the Ghent University. Besides his activity in the Sciensano expert group of TDM\, chemistry and immunochemistry and member of the European Federation of Laboratory Medicine (EFLM)\, he is an active Member of the current Royal Belgian Society of Laboratory Medicine (RBSLM) board.  \n\n\n\nSince 2021\, he is involved in the EFLM Task and Finish Group on Urinalysis under the supervision of Prof. Dr. Timo Kouri. \n\n\n\nAbstract of talk \n\n\n\nOver the last decade\, knowledge of antibodies linked to inflammatory disorders of the central nervous system\, including forms of neuromyelitis optica (NMO) spectrum disorders\, acute disseminated encephalomyelitis (ADEM)\, optic neuritis and transverse myelitis\, has significantly reshaped the landscape of the diagnosis and clinical care. Notably\, highly specific antibody assays have become an integral part of clinical decision making and include antibodies directed against the aquaporin-4 and anti–myelin oligodendrocyte glycoprotein (MOG). \n\n\n\nVarious assays have been developed to identify and quantify anti-MOG. First generation assays\, including enzyme-linked immunosorbent assays (ELISA) and western blots\, are characterized by a poor sensitivity and specificity. To tackle this disadvantage\, during the past 10 years\, cell-based assays (CBA) in which the recombinant antigen is expressed in its natural confirmation have been developed. Immunofluorescence or flow cytometry is subsequently employed to visualize and quantify antibody binding. Both live and fixed cell CBAs are utilized\, offering enhanced sensitivity and specificity. Moreover\, techniques such as immunoprecipitation provide complementary means for MOG antibody detection\, allowing for confirmation and characterization of MOG antibody subtypes. The selection of an appropriate assay depends on the diagnostic performance\, as well as the laboratory’s technical capabilities. \n\n\n\nDuring this presentation\, the different assays for the detection of anti-NMO and anti-MOG antibodies will be discussed\, including their performance in the different patient populations. Although a lot of progress has already been made in the development\, further efforts need to be undertaken to standardize the different assays. \n\n\n\n\n\nThis valuable learning experience is made possible through the generous support of our sponsors\, whom we sincerely thank. It’s important to note that while our sponsors contribute to the success of the event\, they have no involvement or influence on the learning content itself. We remain committed to providing an unbiased and enriching educational experience for all participants. \n\n\n\nPlatinum \n\n\n\n\n\n\n\nGold \n\n\n\n\n\n\n\n\n\nFAQSponsored breakoutLocations\n\n\nWhen and where is the event taking place?\n\nThe first edition of the ParadigMS Belgian Symposium will take place on Thursday\, 7th of March 2024 at Dolce La Hulpe Hotel in La Hulpe. The second edition of the ParadigMS Belgian Symposium will take place on Thursday\, 28th of March 2024 at Van der Valk Hotel in Ghent.  \n\n\n\n\n\nHow can I register for the event?\n\nSimply click on REGISTER button you can see above this section and then select your preferred event session and sponsored break-out session. \n\n\n\n\n\nIs there a registration fee?\n\nNo\, this learning experience is offered for free to neurologists across Belgium\, Luxembourg and the Netherlands thanks to the support of the sponsors. Registration is mandatory and seats are limited. \n\n\n\n\n\nWill there be any networking opportunities?\n\nThe seated dinner environment will offer plenty of networking opportunities\, in addition to the Welcome drinks and Desert networking. \n\n\n\n\n\nWill there be a sponsor breakout?\n\nYes\, please refer to the programme for more details.  \n\n\n\n\n\nAre there any accommodations nearby?\n\nBoth venues\, located within hotels\, offer convenient accommodation options for participants.\n\n\n\n\n\nIs there parking available at the venue?\n\nBoth venues provide free parking for participants. Please check the Location tab.\n\n\n\n\n\nCan I bring a guest?\n\nYou can register up to 5 persons per session\, if they are also healthcare professionals with a focus on neurology.\n\n\n\n\n\nHow can I get updates or notifications about the event?\n\nStay connected with all updates and news by subscribing to the ParadigMS Foundation webpage: https://paradigms.foundation/ \n\n\n\n\n\nIs there a dress code for the event?\n\nWe recommend wearing smart casual attire.\n\n\n\n\n\nWill there be food and beverages provided?\n\nYes\, we provide a three-course dinner with a variety of drinks. \n\n\n\n\n\nWhat if I need to cancel my registration?\n\nIf you need to cancel your registration\, please send a message to learning@paradigms.foundation.\n\n\n\n\n\nHow can I become a sponsor of the event?\n\nIf you wish to become a sponsor of this event\, please send a message to learning@paradigms.foundation. \n\n\n\n\n\nWho can I contact for additional information?\n\nIf you have any questions or need further information about either of the two learning experiences\, please feel free to reach out to us at learning@paradigms.foundation. \n\n\n\n\n\nWhat if organisers need to cancel the event?\n\nThe Symposium is organised by LAUREA Group BV in collaboration with ParadigMS Foundation. The organiser reserves the right to cancel the event at any time due to unforeseen circumstances. In that case\, registrants will be notified by email and no compensation can be claimed. \n\n\n\n\n\nWill this symposium be live streamed?\n\n No\, the two live sessions of the Symposium are not live streamed and available only for onsite participants.\n\n\n\n\n\nWhom can register for one of the sessions?\n\nThe Symposium is open for neurologists\, residents and neuroscience nurses from Belgium\, Luxembourg and the Netherlands. If you do not fall within this category\, please ask for prior approval to the ParadigMS secretariat before registering. If you register without prior approval and are not within the welcomed categories\, the organisers reserve the right to cancel your registration. In case of cancellation\, you will be notified. You can contact us via learning@paradigms.foundation.\n\n\n\n\n\nCan I join both the session in La Hulpe and in Ghent?\n\nNo\, in principle it is not allowed to join both sessions. Please note that both sessions have a very similar programme and are organised in a different language. Should you wish to join both sessions\, please contact us prior to your registration. In case of cancellation\, you will be notified. You can contact us via learning@paradigms.foundation.\n\n\n\n\n\nWill there be a written report from the sessions?\n\nYes\, the ParadigMS Secretariat is planning to have a medical writer on site who will be tasked with producing a written report from both sessions.\n\n\n\n\n\nWill any of the sessions be recorded on video for later viewing?\n\nYes\, the keynote of Prof. Marignier in Ghent will be video and audio recorded and will be made available on ParadigMS.foundation. You will need to create a Member account to have access to the recording (conditions to join as a member apply). \n\n\n\n\n\n\n\n\nKeynote \n\n\n\n‘Precision medicine: targeting complement in the prevention of NMOSD relapses‘ \n\n\n\n\n\n\n\nAbstract of talk \n\n\n\nData presented at the meeting will feature insights from Alexion’s complement portfolio illustrating the critical role of C5 inhibition in treating AQP4 Ab+ NMOSD and significantly reducing the risk of relapses\, including data from the phase III trial with the long-acting C5 complement inhibitor ravulizumab. \n\n\n\n\n\n\n\nSpeakers \n\n\n\n\n\n\n\nProf. Dr. Dominique Dive from CHU Liège  \n\n\n\nMarch 7th\, La Hulpe\, 18:15-18:45 CET \n\n\n\nProf. Dr. Dominique Dive has been working on dysimmune diseases of the central nervous system for more than 30 years; it was the development of evoked potentials that led him to focus on multiple sclerosis\, and particularly paediatric multiple sclerosis.  He is a member of several national and international associations. \n\n\n\n\n\n\n\nProf. Dr. Guy Laureys from UZ Gent  \n\n\n\nMarch 28th\, Ghent\, 18:15-18:45 CET \n\n\n\nProf. Dr. Guy Laureys is the head of the neuroinflammatory care unit at the UZ Ghent Department of neurology. As such he is involved in research\, education and treatment of neuroinflammatory disorders. As a member of the ERN-RITA the neuroinflammatory care unit is a reference centre for rare neuroimmunological disorders such as NMO\, MOGAD\, Susac and autoimmune encephalitis. \n\n\n\n\n\n\n\nPracticalities \n\n\n\nBefore joining the sponsored breakout session\, please stop by the Welcome and Registration desk to collect your badge. You will be guided to the breakout room reserved for each session. \n\n\n\n\n\nParadigMS Ninth Belgian Symposium – 1st edition\, March 7\, 2024 \n\n\n\nLocation: Dolce by Wyndham La Hulpe Brussels  \n\n\n\nAddress: Chau. de Bruxelles 135\, 1310 La Hulpe \n\n\n\n\nParking: Participants can park for free at Dolce La Hulpe Hotel’s two parking spaces (P1 – charging stations available\, and P2)\, and then use the hotel main entrance (the blue bubble in the picture). \n\n\n\n\nRegistration and welcome desk: Participants can collect their badges at the Registration and Welcome desk\, located right after the main entrance.  \n\n\n\n\n\n\n\nParadigMS Ninth Belgian Symposium – 2nd edition\, March 28\, 2024 \n\n\n\nLocation: Van der Valk Hotel Gent \n\n\n\nAddress: Akkerhage 10\, 9000 Gent \n\n\n\n\nParking: Participants can park for free at Van der Valk Hotel Gent’s underground parking spaces (H1\, with parking ticket)\, above-ground parking spaces (H2\, with parking ticket) but also in a second parking lot\, namely the Springpress parking lot\, which is the building opposite the hotel (H3\, no parking ticket). \n\n\n\n\nEntrance: Please use the main entrance and ascend the centrally located circular staircase to reach the first floor\, where the symposium takes place.  \n\n\n\nRegistration and welcome desk: Upon reaching the first floor\, kindly stop to acquire your badge from our registration and welcome desk.
URL:https://paradigms.foundation/event/paradigms-belgian-symposium-2024/
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2024/01/LAU-PROD-banner-general-9th-Symposium-1080x655-1.jpg
END:VEVENT
END:VCALENDAR